首页>
外国专利>
PROGNOSTIC CLINICAL RESPONSE BIOMARKERS FOR ANTI-LPS TREATMENT BY IMMUNOGLOBULIN
PROGNOSTIC CLINICAL RESPONSE BIOMARKERS FOR ANTI-LPS TREATMENT BY IMMUNOGLOBULIN
展开▼
机译:免疫球蛋白治疗抗-LPS的预后临床反应生物标志物
展开▼
页面导航
摘要
著录项
相似文献
摘要
The present invention relates to the biomarkers for predicting the clinical response to anti-LPS immunoglobulin treatments in patients in need thereof. In particular, the invention provides methods for predicting the clinical response to an anti-LPS immunoglobulin treatment in a patient in need thereof, said method comprising the steps of evaluating the expression of a predictive biomarker selected from the group consisting of CD14, CD68, TLR4, TLR7, IL6, IL8, IL10, IFN-alpha, IGF1, CXCL1, CXCL9, CXCL10, RAGE, GDNF, BCHE, and combination thereof, in said patient.
展开▼